The Subjective Effects of Psychedelics Are Necessary for Their Enduring Therapeutic Effects Read More > December 10, 2021
Safety of ibogaine administration in detoxification of opioid-dependent individuals: a descriptive open-label observational study Read More > August 9, 2021
Risk assessment of ayahuasca use in a religious context: self-reported risk factors and adverse effects Read More > July 1, 2021
Habenula Connectivity and Intravenous Ketamine in Treatment-Resistant Depression Read More > May 18, 2021
Effects of Ayahuasca on the Recognition of Facial Expressions of Emotions in Naive Healthy Volunteers: A Pilot, Proof-of-Concept, Randomized Controlled Trial Read More > May 1, 2021
Effects of Psilocybin-Assisted Therapy on Major Depressive Disorder: A Randomized Clinical Trial Read More > May 1, 2021
Harnessing psilocybin: antidepressant-like behavioral and synaptic actions of psilocybin are independent of 5-HT2R activation in mice Read More > April 27, 2021
